Related Experiment Video
Updated: Jul 15, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Tests for Helicobacter pylori infection: a critical appraisal from primary care
A P Roberts1, S M Childs, G Rubin
1Centre for Health Studies, University of Durham, 32 Old Elvet, Durham DH1 3HN, UK.
Background:
Testing of patients for Helicobacter pylori infection is common in primary care settings. The accuracy of such tests has been assessed and critical appraisal of this literature can inform the clinical management of patients suspected of being infected with H. pylori
Methods:
Literature evaluating the accuracy of diagnostic tests for H.pylori infection was sought as part of a systematic review of literature concerning the management of patients infected with H.pylori Studies were appraised and estimates of sensitivity and specificity were extracted. Positive and negative likelihood ratios (LRs) were calculated and the implications for post-test probabilities are reported.
Results:
The sensitivity, specificity, LR+ and LR- for H.pylori infection tests ar: [(13)C]urea breath test (UBT), 96.5, 96, 24 and 0.04; [(14)C]UBT, 97.5, 95.5, 21 and 0.03; serology, 91, 89.5, 8 and 0.11; near patient tests, 77, 74, 3 and 0. 31; and meta-analysis of serology, 85, 79, 4 and 0.19. The range of pre-test probabilities of H.pylori infection in which the diagnostic tests were useful, estimated from primary studies, wer: [(13)C]UBT, 20-90%; [(14)C]UBT, 20-99%; serology, 30-80%; and near patient tests, 50-60%.
Conclusions:
Tests for H.pylori infection are useful in primary care when the pre-test probability of infection is neither too high nor too low. This indicates that the tests may not be useful for screening purposes but may help with differential diagnosis. Outside moderate pre-test probability ranges, the chances of a result being false is high, and such patients should either receive eradication without prior testing (if the probability of infection is sufficiently high) or the test result should be reconfirmed. When the pre-test probability falls below approximately 20%, a positive test result is unreliable. If the pre-test probability is above approximately 80%, a negative test result is unreliable. Clinical selection of patients needing testing should be used to limit testing to individuals with pre-test probabilities within these ranges. The choice of diagnostic H.pylori test should be influenced by the H.pylori infection rate in the population being tested and the test characteristics. Recommendations for the use of tests, especially near patient tests, should be reconsidered. This critical appraisal supports the recommendations of the European Society for Primary Care Gastroenterology guidelines, arrived at by consensus, for testing for H.pylori infection in primary care.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Serum Laboratory Studies, Stool Test, Breath Test
Peptic Ulcer